< Back to latest news & events

Event

Webinar: Attracting big pharma to the Microbiome field

June 2020

Event date: 8th July 2020

HGF Partners Craig Thomson and Dr Andrew Wells will be presenting a webinar on ‘Attracting Big Pharma to the Microbiome Field’ on 8th July.

Join ‘Attracting Big Pharma to the Microbiome Field’ webinar by Arrowhead Publishers on 8th July at 1PM (CDT), where the presenters will discuss:

  • the advantages and disadvantages of engaging with Big Pharma
  • what attracts Big Pharma and broadly at the options open in the microbiome field
  • “Drugs from bugs” (bio-active molecules derived from bacteria), “Bugs as drugs” (therapeutic bacteria and phage with combinations of such from single strain to FMT), “Bugs for drugs” (the use of bacteria as adjuvant technology for enhancing “conventional” therapeutics)
  • hints and tips for those preparing to pitch their technology to one of the Big Pharma

HGF Partner Craig Thomson will be chairing a discussion between HGF Partner Dr Andrew Wells and Executive Director and Head of Investigational Biology at Merck’s Exploratory Science Center (ESC), who both have direct experience of what Big Pharma look for in emerging technologies.

Latest updates

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Read article

Colour in fashion and the difficulties of protecting it

Episode 2 Colour in fashion and the difficulties of protecting it  

Read article